Clinical Trial Update: FULIRI Plus Targeted Therapy for First-line Conversion Therapy of Colorectal Cancer Liver Metastases. [Phase 2]

View source ↗

Summary

This Phase 2 study investigates FULIRI plus a targeted therapy as first-line conversion treatment for colorectal cancer with liver metastases; the trial is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FULIRI

Snippet

Sponsor: Zhongnan Hospital | Conditions: Colo-rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING